These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5555145)

  • 1. [Heparin-adrenaline complex as a humoral agent of the anticoagulation system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1971; 17(1):46-53. PubMed ID: 5555145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor XIII-heparin complex and its properties as a physiological solvent for unstabilized fibrin].
    Ul'ianov AM; Kudriashov BA
    Vopr Med Khim; 1975; 21(1):19-23. PubMed ID: 235172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of I-131 labeled factor XIII in animals before and after stimulation excitation of the anticoagulation system].
    Ul'ianov AM; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1974 Aug; 60(8):1193-8. PubMed ID: 4426435
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combined administration of EACA and heparin on thrombus weight and fibrinolysis. An experimental study.
    Komatsu K; Hayakawa D; Suzuki K; Tomita S; Fukushima Y
    Bull Tokyo Med Dent Univ; 1973 Mar; 20(1):93-104. PubMed ID: 4515656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complexes of heparin with antiplasmins and several of their properties].
    Pastorova VE; Kudrashov BA; Rodina VI
    Vopr Med Khim; 1973; 19(5):492-7. PubMed ID: 4788172
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of non-enzymatic inhibitor of fibrinolysis from the splenic tissue on the activity of the heparin-antithrombin III-thrombin complex in vitro and during activation of the anticoagulation system].
    Liapina LA; Pastorova VE; Kudriashov BA
    Fiziol Cheloveka; 1988; 14(4):629-34. PubMed ID: 3215406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin-antifibrinolysin complex and its role in the anticoagulation system].
    Kudriashov BA; Pastorova VE; Glotova VL
    Vopr Med Khim; 1967; 13(1):29-33. PubMed ID: 5615047
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D; Tyler HM
    Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of an adrenaline-heparin complex on blood lipolytic activity in animals during normal and depressed states of the anticoagulation system].
    Bazaz'ian GG; Liapina LA; Mendelevich OA
    Vopr Med Khim; 1974; 20(5):476-82. PubMed ID: 4456797
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of thrombin and adrenaline for the development of secondary anticoagulation system (SAC) in experimental animals].
    Kudrjashov BA; Ljapina LA; Kovaleva TN
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):76-84. PubMed ID: 4121133
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV
    Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM; Kudriashov BA; Liapina LA
    Biokhimiia; 1973; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental data on the existence and significance of an anticoagulating system in fish].
    Kudriashov BA; Kalishevskaia TM; Bazaz'ian GG; Volkov VN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 2():31-6. PubMed ID: 4824513
    [No Abstract]   [Full Text] [Related]  

  • 18. [The heparin-epinephrine complex as humoral factor in the anticoagulatory system].
    Kudrjashov BA; Liapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):272-84. PubMed ID: 4106019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.